Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests

[1]  A. Mathieu,et al.  The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis. , 2012, Seminars in arthritis and rheumatism.

[2]  I. Wicks,et al.  Cardiovascular disease in systemic sclerosis - an emerging association? , 2011, Arthritis research & therapy.

[3]  E. Picano,et al.  Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery , 2011, Heart.

[4]  E. Picano.  The Risks of Inappropriateness in Cardiac Imaging , 2009, International journal of environmental research and public health.

[5]  A. Chiti,et al.  Myocardial involvement in systemic sclerosis. , 2008, Rheumatology.

[6]  L. Mouthon,et al.  Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. , 2008, Arthritis and rheumatism.

[7]  S. Iliceto,et al.  Effect of a single IV administration of L-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. , 2007, Clinical therapeutics.

[8]  P. Colonna,et al.  Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography: a myocardial echostress scleroderma pattern , 2006, Annals of the rheumatic diseases.

[9]  C. Denton,et al.  Angiographically proven coronary artery disease in scleroderma. , 2006, Rheumatology.

[10]  Y. Allanore,et al.  Primary myocardial involvement in systemic sclerosis. , 2006, Rheumatology.

[11]  E. Picano,et al.  The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy. , 2006, European heart journal.

[12]  J. Zamorano,et al.  Prognosis of coronary flow reserve: a new therapeutic target? , 2006, European heart journal.

[13]  P. Colonna,et al.  Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction , 2006, Heart.

[14]  P. Siotto,et al.  Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve , 2006, Annals of the rheumatic diseases.

[15]  M. Emdin,et al.  Heart involvement and systemic sclerosis , 2005, Lupus.

[16]  O. Vignaux,et al.  Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis , 2005, Annals of the rheumatic diseases.

[17]  F. Manguso,et al.  Echocardiographic alterations in systemic sclerosis: a longitudinal study. , 2005, Seminars in arthritis and rheumatism.

[18]  L. Czirják,et al.  Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis , 1995, Clinical Rheumatology.

[19]  J. Ioannidis,et al.  Mortality in systemic sclerosis: an international meta-analysis of individual patient data. , 2005, The American journal of medicine.

[20]  Eugenio Picano,et al.  Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno , 2004, BMJ : British Medical Journal.

[21]  J. Tanne.  US accrediting agency tightens rules for continuing medical education , 2004, BMJ : British Medical Journal.

[22]  D. Duboc,et al.  High prevalence of right ventricular systolic dysfunction in early systemic sclerosis. , 2004, The Journal of rheumatology.

[23]  M. Cutolo,et al.  Blunted coronary flow reserve in systemic sclerosis. , 2004, Rheumatology.

[24]  P. Colonna,et al.  Detection of early impairment of coronary flow reserve in patients with systemic sclerosis , 2003, Annals of the rheumatic diseases.

[25]  A. Raviele,et al.  Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. , 2003, The American journal of cardiology.

[26]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[27]  B. Usher,et al.  Recent advances in dobutamine stress echocardiography , 2000, Clinical cardiology.

[28]  H. Seo,et al.  Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison among adenosine, standard-dose dipyridamole, and high-dose dipyridamole. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[29]  R. Doughty,et al.  Left ventricular function in scleroderma. , 1996, British journal of rheumatology.

[30]  M. Condorelli,et al.  Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. , 1996, Annals of the rheumatic diseases.

[31]  T. Medsger,et al.  Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. , 1996, Arthritis and rheumatism.

[32]  Kahaleh Mb.  The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response. , 1990 .

[33]  Miller Tr,et al.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). , 1990, The Journal of rheumatology.

[34]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[35]  F. Mannting,et al.  COLD-INDUCED REVERSIBLE MYOCARDIAL ISCHAEMIA IN SYSTEMIC SCLEROSIS , 1989, The Lancet.

[36]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[37]  A. Romorini,et al.  [Cardiac involvement in scleroderma]. , 1988, Medicina cutanea ibero-latino-americana.

[38]  J. Weiss,et al.  Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. , 1986, Annals of internal medicine.

[39]  W. Follansbee.  The cardiovascular manifestations of systemic sclerosis (scleroderma). , 1986, Current problems in cardiology.

[40]  B. Amor,et al.  Decreased coronary reserve in primary scleroderma myocardial disease. , 1985, Arthritis and rheumatism.

[41]  T. Medsger,et al.  Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. , 1984, The American journal of medicine.

[42]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[43]  D. Furst,et al.  The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. , 1981, Annals of internal medicine.

[44]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[45]  G. Hutchins,et al.  Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. , 1978, American heart journal.

[46]  E. Pastor,et al.  [Cardiac involvement in progressive systemic sclerosis]. , 1977, Arquivos brasileiros de cardiologia.

[47]  G. Hutchins,et al.  Myocardial Lesions of Progressive Systemic Sclerosis: A Cause of Cardiac Dysfunction , 1976, Circulation.

[48]  T. N. James,et al.  De Subitaneis Mortibus: VIII. Coronary Arteries and Conduction System in Scleroderma Heart Disease , 1974, Circulation.

[49]  T. K. Marshall,et al.  De Subitaneis Mortibus: V. Occluded A‐V Node Artery , 1974, Circulation.

[50]  J. Fries,et al.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. , 1969, The American journal of medicine.